Ian Shott is Managing Director of Arcinova, a contract research and development company, and Shott Trinova through which he invests in, chairs and leads a portfolio of life science businesses. In 2004 he founded Excelsyn, a Pharmaceutical Development business, which he sold to US multinational AMRI in 2010. Ian previously held several global leadership positions, with multi-national life science companies (ICI, AstraZeneca, Lonza, ChiRex and Rhodia).
Chair of the Royal Academy of Engineering Enterprise Committee, Ian has played a prominent role in establishing their Enterprise Hub.
Ian has a history of transforming technology-based businesses to deliver exceptional results.. He has a wealth of experience with major industry bodies and is currently the Chair of Accelerated Innovation for the Chemistry Growth Partnership part of the Government’s Industrial Strategy. He was a Governing Board Member of Innovate UK and founding chair of the Industrial Biotechnology Leadership Forum for over six-years. Ian holds visiting professorships at Oxford, Nottingham and Newcastle Universities and is the founding chair of the Industrial Biotechnology Innovation Centre.
